CanFite

IPO

Innovative drug development targeting the A3 adenosine receptor

Petah Tikva, Israel · Founded 1994 · $15.0M raised

Headquarters
Petah Tikva
Employees
11–50
Founded
1994
Business Model
B2B
Total Funding
$15.0M
Last Round
$15.0M Corporate RoundJul 2025
Rounds
1

About

Can-Fite BioPharma is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary drug candidates in Phase II and Phase III clinical development addressing oncology, inflammatory, and metabolic diseases. Can-Fite's platform technology utilizes the Gi protein-associated A3 adenosine receptor (A3AR) as a therapeutic target — highly expressed in inflammatory and cancer cells while showing low expression in normal cells, making it a unique pharmacological target. Founded in 1994 by Pnina Fishman and Ilan Cohn, Can-Fite is headquartered in Petah Tikva, Israel and is listed on both the Tel Aviv Stock Exchange (TASE:CFBI) and NYSE American (CANF).

Summary

CanFite is a Biotech company based in Petah Tikva, Israel, founded in 1994. It has raised $15.0M in total across 1 round, most recently a $15.0M Corporate Round round in Jul 2025. Investors include Giza Venture Capital.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundJul 2025
$15.0M

Sign up to see all 3 rounds

IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CanFite on Indexed.vc
<a href="https://indexed.vc/companies/canfite"><img src="https://indexed.vc/api/badge/company/canfite" alt="CanFite on Indexed.vc" width="260" height="76" /></a>